FeesSafety
Pluang+

Payward aims to launch first CFTC-regulated perpetual futures on Hyperliquid's new HIP-3* market protocol.

Market News
27 Oct 2026, 01:21 WIB
Blockonomi
View Source
Bullish
Payward aims to launch first CFTC-regulated perpetual futures on Hyperliquid's new HIP-3* market protocol.

Payward, Kraken's parent company, plans to become the first CFTC-regulated deployer on Hyperliquid's HIP-3* perpetual futures markets, targeting U.S. clients. Bitnomial, a regulated exchange and clearinghouse under Payward, would deploy and clear these markets, while NinjaTrader Clearing would manage client accounts, all pending regulatory approval. HIP-3* introduces optional onchain allowlists for permissioned markets, allowing deployers to control market access without affecting existing markets. The initial HIP-3* version is live on testnet, with specifications subject to change based on feedback, marking a potential new regulated infrastructure layer for U.S. perpetual futures trading.

Kraken parent Payward's plan to become the first CFTC-regulated HIP-3* deployer on Hyperliquid is presented here with Pluang's market data for context. As of Oct 27, 2026 05:02 WIB, among 50 major cryptocurrencies on Pluang, 24 rose and 24 fell. Notably, BAT fell 5.68% to Rp2.579 with 95% buy orders and a typical hold time of 93 days, contrasting with CAKE which rose 4.61% to Rp38.790 with 65% buy orders and a shorter hold time of 75 days, while ZIL increased 3.75% to Rp35 but had a majority 58% sell order activity and the longest hold time of 134 days.

More News

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement to announce Q3 2026 financial results on Nov 9 with a webcast.

Exodus Movement, a self-custodial finance and payments platform, will release its third quarter 2026 financial results after market close on November 9, 2026. The company will host a webcast at 5:00 PM ET the same day to discuss the results. Founded ...

Company Fundamentals
Neutral
1 hour ago
Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360 named national pharmacy partner for AstraZeneca's lung cancer drug Zegfrovy.

Onco360, a leading independent specialty pharmacy, has been selected by AstraZeneca as a national pharmacy partner for Zegfrovy (sunvozertinib), a treatment for advanced non-small cell lung cancer with EGFR exon 20 insertion mutations. Zegfrovy has s...

Market News
Bullish
1 hour ago
S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions joins SAP PartnerEdge program, boosting its SAP consulting capabilities.

S4A IT Solutions has been accepted into the SAP PartnerEdge program, marking a key milestone in its growth. This partnership enhances S4A's ability to help organizations maximize their SAP investments, especially in areas like asset management and su...

Market News
Bullish
1 hour ago
SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

SEC policy shifts and rising shareholder activism shape 2027 proxy season preparations for public companies

Public companies are facing new challenges for the 2027 proxy season due to changes in SEC policies, evolving shareholder activism strategies, and shifts in institutional investor voting. A virtual roundtable on October 28 will gather experts to disc...

Market News
Neutral
3 hours ago
Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo to release Q3 2026 earnings on Nov 6 with a conference call for analysts.

Gogo Inc., a leading provider of in-flight broadband connectivity, announced it will report its third quarter 2026 financial results on November 6, 2026, before the market opens. The company will hold a conference call with financial analysts the sam...

Company Fundamentals
Neutral
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App